Wide Spectrum of Molecular and Clinical Heterogeneity in HbH Disease in North Indian Patients

Author:

Das Reena1,Fisher Chris2,Kaur Jasbir3,Helena Ayyub2,Trehan Amita4,Bansal Deepak1,Sharma Prashant1,Malhotra Pankaj5,Douglas Higgs6,Weatherall David J7

Affiliation:

1. Postgraduate Institute of Medical Education and Research, Chandigarh, India

2. Weatherall Institute of Molecular Medicine, Oxford, United Kingdom

3. Postgraduate Institute of Medical Education and Research, Chandigarh, India 160012, Chandigarh, India

4. Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India

5. PGIMER, CHANDIGARH, India

6. Medical Research Council Molecular Haematology Unit, Oxford, United Kingdom

7. University of Oxford, Oxford, United Kingdom

Abstract

Abstract Background: Deletional a+-thalassemia comprising of -a3.7 and -a4.2 deletions is commonly encountered in the Indian sub-continent but HbH disease, resulting from the co-inheritance of a+-thalassemia trait and ao-thalassemia trait, is uncommon with just a few cases reported. Few recent reports on the molecular characterization of patients with HbH disease from India has been published which includes both deletional a-thalassemia and non-deletional a-thalassemia. This report highlights the clinical and molecular heterogeneity of HbH disease from north India. Materials and Methods: We encountered 34 patients with HbH disease in 28 families from north India over 15 years and performed the molecular analysis to determine the frequency of both deletional and non-deletional alpha gene defects. Patients as well as parents and affected siblings were also studied for automated complete blood cell counts, reticulocyte counts and HbH inclusions using 1% brilliant cresyl blue. Cation exchange HPLC (Bio-Rad Laboratories, Hercules, CA, USA) and hemoglobin electrophoresis at pH 8.6 were performed. Genomic DNA from peripheral blood leucocytes was extracted by the phenol-chloroform method. A multiplex Gap-PCR was carried out as an initial screen which tested for deletions a3.7, a4.2, aSEA, aMED and aSA. Southern Blot for alpha and zeta probes with Bam H1 digest was performed on 20 subjects. PCR followed by sequencing for both a1 and a2 genes were done. The a–GlobinXS MLPA kit (MRC Holland) with 35 probes was used to screen for the extent of deletions. Results: Homozygous Hb Sallanches (a2 codon 104 G>A; Cys →Tyr) in 6 cases in 5 families was found. Homozygous polyadenylation signal mutation of a2(-AA) AATAAA →AATA—was detected in 3 cases. One patient each showed double heterozygosity for -a3.7/aHb Sallanches a, a76 +Ta/aHb Sallanches a. PolyAa/ aHb Sun Prairie a, aPolyAa/ a76 +Ta, and -a3.7/aHb Seal Rocka and aSeal Rock a/--. Three patients were double heterozygous for -a3.7/--SA. Fifteen patients from 12 families had a0 deletion of varying lengths in combination with -a3.7 based on the MLPA analysis. The extent of deletions was variable ranging from a0 starts upstream of z gene & extends downstream of a1, deletion of probes 1-18, deletion of probes 1-22 and deletion of probes 8-18.The genotype phenotype correlation illustrating the clinical heterogeneity of HbH disease is detailed in Table 1. Discussion: This is the largest series of cases of HbH disease encountered in Indians. Since HbH disease is uncommon in India, the clinical recognition of the diagnosis is limited to few centres and molecular characterization is incomplete. Our study shows considerable heterogeneity both at the molecular level as well as the clinical presentation. Alpha2 gene sequencing revealed a novel mutation with addition of +T at codon 76 leading to a frameshift mutation .MLPA will be useful in characterizing the approximate location of the breakpoints and designing simple GAP PCR assays to identify the deletion. Increased awareness amongst the clinicians as well as more diagnostic laboratories will help to identify more patients with HbH disease. Table 1: Genotype and phenotype correlation of cases with HbH Number of cases Clinical Severity Homozygous Hb Sallanches 6 cases (5 families) Severe anemia with early presentation Homozygous aPolyAa/ aPolyAa 3 cases Moderate anemia with presentation in the second decade Double heterozygous -a3.7/aHb Sallanches a 1 case Moderate anemia Double heterozygous a76 +Ta/aHb Sallanches a 1 case Moderate anemia with presentation in the third decade Double heterozygous aPolyAa/ aHb Sun Prairie a 1 case Moderate anemia with early presentation Double heterozygous aPolyAa/ a76 +Ta 1 case Moderate anemia with early presentation Homozygous a2 Codon 19 (-G) 1 case Severe anemia with early presentation Double heterozygous for -a3.7/--SA 3 cases Moderate anemia with presentation in the third decade Double heterozygous for aSeal Rock a/-- 1 case Severe anemia with early presentation Double heterozygous for -a3.7/aSeal Rock a 1 case Mild presentation at family screening in forth decade with mild anemia Double heterozygosity for -a3.7/-- 15 cases (13 families) Larger deletions showed early presentation with severe anemia and shorter deletions showed mild anemia Disclosures No relevant conflicts of interest to declare.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3